IL2 and metastatic melanoma: For instance, a preliminary report in 20 patients with metastatic melanoma treated with TIL therapy and IL-2 after a single intravenous dose of cyclophosphamide as lymphodepletion resulted in response rates of 60% in IL-2 naïve patients and 40% in patients with prior IL-2 exposure [5].